PROZAC WEEKLY Drug Patent Profile

✉ Email this page to a colleague

When do Prozac Weekly patents expire, and what generic alternatives are available?

Prozac Weekly is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in PROZAC WEEKLY is fluoxetine hydrochloride. There are twenty-seven drug master file entries for this compound. Seventy-one suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Prozac Weekly

A generic version of PROZAC WEEKLY was approved as fluoxetine hydrochloride by APNAR PHARMA LP on August 2^nd, 2001.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for PROZAC WEEKLY?
What are the global sales for PROZAC WEEKLY?
What is Average Wholesale Price for PROZAC WEEKLY?

Summary for PROZAC WEEKLY

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	174
Clinical Trials:	110
Patent Applications:	5,914
DailyMed Link:	PROZAC WEEKLY at DailyMed

Drug patent expirations by year for PROZAC WEEKLY

Recent Clinical Trials for PROZAC WEEKLY

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Avy L. & Roberta L. Miller Foundation	Phase 2
Stanford University	Phase 2
Milton S. Hershey Medical Center	Early Phase 1

See all PROZAC WEEKLY clinical trials

US Patents and Regulatory Information for PROZAC WEEKLY

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lilly	PROZAC WEEKLY	fluoxetine hydrochloride	CAPSULE, DELAYED REL PELLETS;ORAL	021235-001	Feb 26, 2001		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PROZAC WEEKLY

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lilly	PROZAC WEEKLY	fluoxetine hydrochloride	CAPSULE, DELAYED REL PELLETS;ORAL	021235-001	Feb 26, 2001	⤷ Sign Up	⤷ Sign Up
Lilly	PROZAC WEEKLY	fluoxetine hydrochloride	CAPSULE, DELAYED REL PELLETS;ORAL	021235-001	Feb 26, 2001	⤷ Sign Up	⤷ Sign Up
Lilly	PROZAC WEEKLY	fluoxetine hydrochloride	CAPSULE, DELAYED REL PELLETS;ORAL	021235-001	Feb 26, 2001	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for PROZAC WEEKLY

See the table below for patents covering PROZAC WEEKLY around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Switzerland	693018	Magensäureresistente Fluoxetinpellets	⤷ Sign Up
Luxembourg	90245		⤷ Sign Up
Lithuania	98058		⤷ Sign Up
Poland	326134		⤷ Sign Up
Norway	317743		⤷ Sign Up
El Salvador	1998000052	PILDORAS ENTERICAS DE FLUOXETINA REF. X-10709	⤷ Sign Up
Latvia	12176	ZARNĀS ŠĶĪSTOŠI FLUOKSETĪNA ZIRNĪŠI (FLUOXETINE ENTERIC PELLETS)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for PROZAC WEEKLY

Recent Clinical Trials for PROZAC WEEKLY

Make Better Decisions: Try a trial or see plans & pricing